Note the larger hair follicles (elongated columns) in the lower photo, the increased content of subcutaneous fat in the skin (white material in the center of the skin), and the increased thickness of the skin
This FDA-approved methodology penetrates tissues, organs, and bones, to reactivate electrochemical function, regenerate nerve fibers, and enhance motor control
Burks, S
Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)
(2) The Human Evidence Gap No completed, peer-reviewed Phase II or Phase III randomized controlled trials in humans have been published as of July 2025
A 2026 UK review of how HGF activates repair Schwann cells (Ko 2018, Scientific Reports ), the 2021 rat sciatic-nerve study where Dihexa + stem cells improved motor recovery, the VM202 / Engensis HGF gene-therapy Phase 3 in painful diabetic peripheral neuropathy (results posted Jan 2025), chemotherapy-induced neuropathy (CIPN) and the duloxetine question, and the 2026 AthiraLeonaBio pivot taking the oral HGF/MET modulator ATH-1105 into ALS with an honest account of why Dihexa still has zero human neuropathy data Read the full review Neuroscience 27 May 2026 Dihexa for Migraine & Chronic Migraine: The 2026 UK Review Rigorous 2026 UK review of Dihexa for migraine and chronic migraine